Company: PATH
Filing Date: 2025-06-03
Form Type: 10-Q
Source: 0001734722-25-000030
Chunk: 67

Company: UiPath, Inc.
Filing Date: 2025-06-03
Form: 10-Q
Item: Part I, Item 8
Chunk 67
---
 consolidated financial statements.

8

Table of ContentsUiPath, Inc.Notes to Condensed Consolidated Financial Statements (Continued)(unaudited)

3. Revenue Recognition

Disaggregation of RevenueThe following tables summarize revenue by geographical region (dollars in thousands): Three Months Ended April 30,20252024AmountPercentage of RevenueAmountPercentage of RevenueAmericas (1)$161,407 45 %$153,111 46 %Europe, Middle East, and Africa123,664 35 %104,627 31 %Asia-Pacific (2)71,553 20 %77,374 23 %Total revenue$356,624 100 %$335,112 100 %(1)Revenue from the U.S. represented 42% and 42% of our total revenues for the three months ended April 30, 2025 and 2024, respectively.(2)Revenue from Japan represented 10% and 13% of our total revenues for the three months ended April 30, 2025 and 2024, respectively.Deferred RevenueDuring the three months ended April 30, 2025 and 2024, we recognized $210.3 million and $182.3 million of revenue that was included in the deferred revenue balance as of January 31, 2025 and 2024, respectively.Remaining Performance ObligationsOur remaining performance obligations are comprised of licenses, subscription services, and professional services not yet delivered. As of April 30, 2025, the aggregate amount of the transaction price allocated to remaining performance obligations was $1,231.3 million, which consists of $672.0 million of billed consideration and $559.3 million of unbilled consideration. We expect to recognize 63% of our remaining performance obligations as revenue over the next 12 months, and the remainder thereafter.Deferred Contract Acquisition CostsOur deferred contract acquisition costs are comprised of sales commissions that represent incremental costs to obtain customer contracts, and are determined based on sales compensation plans. Amortization of deferred contract acquisition costs was $21.3 million and $18.5 million for the three months ended April 30, 2025, and 2024, respectively, and is recorded in sales and marketing expense in the condensed consolidated statements of operations.

4. Marketable Securities

The following is a summary of our marketable securities (in thousands): As of April 30, 2025Amortized CostGross